PROMENTIS PHARMACEUTICALS, INC.

Profile

Company Names

PROMENTIS PHARMACEUTICALS, INC.

Addresses

826 N. PLANKINTON AVE., STE. 400, MILWAUKEE, WI 53203

826 N. PLANKINTON AVE., STE. 300, MILWAUKEE, WI 53203

Phone Numbers

414-238-2992
262-302-9039

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$32,119,354.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-12-10 
$2,500,000.00 
$6,000,000.00 
$3,500,000.00 
Debt 
5
2017-09-08 
$17,574,799.00 
$17,574,799.00 
$0.00 
Equity 
4
2016-09-21 
$8,787,399.00 
$8,787,399.00 
$0.00 
Equity 
3
2013-12-30 
$820,156.00 
$2,870,156.00 
$2,050,000.00 
Equity 
2
2013-03-18 
$750,000.00 
$750,000.00 
$0.00 
Debt 
1
2009-08-14 
$1,687,000.00 
$2,500,000.00 
$813,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BAKER, PHD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
DAVID 
A 
BAKER, PHD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
DAVID 
A. 
BAKER, PHD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
ED 
 
BARTHELL 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
ED 
 
BARTHELL, MD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
THOMAS 
 
BECK 
DIRECTOR
VICEPT THERAPEUTICS, INC.   |  MERSANA THERAPEUTICS INC   |  DIMENSION THERAPEUTICS, INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  MERSANA THERAPEUTICS, INC.   |  R2I HOLDINGS, LLC   |  AKRIVEIA THERAPEUTICS, LLC   |  PROMENTIS PHARMACEUTICALS, INC.
TOM 
 
BECK 
EXECUTIVE OFFICER, DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  SWAN VALLEY MEDICAL, INC
CHAD 
 
BEYER 
EXECUTIVE OFFICER
PROMENTIS PHARMACEUTICALS, INC.
CHAD 
E 
BEYER, PHD 
EXECUTIVE OFFICER, DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
DANIEL 
 
LAWTON 
DIRECTOR, EXECUTIVE OFFICER
PROMENTIS PHARMACEUTICALS, INC.
VIRINDER 
 
NOHRIA, PHD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
PATRICK 
 
SCHWARZ-SCHUETTE 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
STACEY 
 
SELTZER 
DIRECTOR
MIRAMAR LABS INC   |  MIRAMAR LABS, INC.   |  PROMENTIS PHARMACEUTICALS, INC.   |  RENEO PHARMACEUTICALS, INC.
THOMAS 
 
SHANNON 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  PROXIM DIAGNOSTICS CORP   |  OKANJO PARTNERS, INC.   |  BRACES ON DEMAND, INC.
STEVE 
 
SQUINTO 
DIRECTOR
AUDENTES THERAPEUTICS, INC.   |  PROMENTIS PHARMACEUTICALS, INC.
KLAUS 
 
VEITINGER 
EXECUTIVE OFFICER, DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  BIOLEX THERAPEUTICS, INC.   |  RELYPSA INC   |  INTERCEPT PHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  TRICIDA, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  NEUROGASTRX, INC.   |  ALPHEUS MEDICAL, INC.
KLAUS 
 
VEITINGER, MD, PHD 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-12-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-10 
2017-09-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-08 
2016-10-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-21 
2014-01-15
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2013-12-30 
2013-04-01
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2013-03-18 
2009-08-31
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-08-14 
2009-08-28
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-08-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#